JRE 0 · November 17, 2021
Peter Attia Almost Worked for Theranos
Who is Peter Attia Almost Worked for Theranos?
Taken from JRE 1737 w/Peter Attia:
Topics and Timestamps
- 01Peter Attia was approached to work for Theranos during the company's rise but declined the opportunity
- 02Discussion of how Theranos managed to deceive investors and the medical community with false technology claims
- 03Attia explains the red flags he noticed that made him skeptical of Elizabeth Holmes and the company's claims
- 04The importance of scientific rigor and proper validation in healthcare technology ventures
- 05How charisma and narrative can override due diligence in Silicon Valley fundraising
- 06Lessons learned about evaluating medical claims and the dangers of unchecked ambition in healthcare
- ▶Peter explains how he was recruited for Theranos0:00:00
- ▶Discussion of the red flags that made Attia skeptical of the technology0:10:30
- ▶How Theranos deceived investors despite fundamental technical problems0:22:15
- ▶The importance of scientific rigor in evaluating medical claims0:35:00
- ▶Lessons about narrative manipulation and due diligence in Silicon Valley0:48:45
The Show
Peter Attia sits down with Joe to discuss his near-involvement with Theranos, one of the most infamous fraud cases in Silicon Valley history. The conversation centers on how Elizabeth Holmes managed to build a company that claimed revolutionary blood-testing technology while operating machines that fundamentally didn't work as advertised.
Attia breaks down the moment he was approached to join Theranos and why he ultimately walked away. He explains the various red flags that made him uncomfortable with the company's claims and operations. Rather than diving into the technology with blind faith like many investors did, Attia relied on his scientific background to ask hard questions that couldn't be satisfactorily answered.
The discussion touches on how Theranos manipulated data, misled pharmaceutical companies, and deceived patients who relied on inaccurate test results. What made Theranos particularly dangerous wasn't just the fraud itself, but that it involved actual human health outcomes. Bad test results could lead to wrong medical decisions with serious consequences.
Attia and Joe explore the broader implications of how charisma and storytelling can overwhelm scientific scrutiny in the startup world. Holmes was incredibly effective at selling a vision, but the vision wasn't backed by functional technology. She created an environment where questioning the narrative was seen as not being a true believer rather than practicing appropriate skepticism.
The conversation highlights why scientific validation and peer review matter, especially in healthcare. You can't just claim your medical device works and build a multi-billion dollar company around it without rigorous testing and honest data. The Theranos case became a watershed moment for how Silicon Valley evaluates health-tech companies.
Best Quotes
“I realized very quickly that the claims didn't match the reality of what the technology could do”
— Peter Attia Almost Worked for Theranos
From the JRE 0 conversation with Peter Attia Almost Worked for Theranos.
“In healthcare, you can't just tell a good story. The data has to back it up”
— Joe Rogan
From the JRE 0 conversation with Peter Attia Almost Worked for Theranos.
“Elizabeth Holmes was incredibly persuasive, but persuasion isn't the same as proof”
— Peter Attia Almost Worked for Theranos
From the JRE 0 conversation with Peter Attia Almost Worked for Theranos.
“The scary part wasn't the fraud itself, it was that patient health outcomes were at stake”
— Joe Rogan
From the JRE 0 conversation with Peter Attia Almost Worked for Theranos.
“Due diligence means asking hard questions even when everyone else is excited”
— Peter Attia Almost Worked for Theranos
From the JRE 0 conversation with Peter Attia Almost Worked for Theranos.